APA (7th ed.) Citation

denHaak, D. A. C. v., Otten, L., Koenen, H. J. P. M., Smeets, R. L., Piet, B., Pickkers, P., . . . ter Heine, R. (2023). Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression. Wiley.

Chicago Style (17th ed.) Citation

denHaak, Demy A. C. van, Leila‐Sophie Otten, Hans J. P. M. Koenen, Ruben L. Smeets, Berber Piet, Peter Pickkers, Matthijs Kox, and Rob ter Heine. Evidence‐based Rationale for Low Dose Nivolumab in Critically Ill Patients with Sepsis‐induced Immunosuppression. Wiley, 2023.

MLA (9th ed.) Citation

denHaak, Demy A. C. van, et al. Evidence‐based Rationale for Low Dose Nivolumab in Critically Ill Patients with Sepsis‐induced Immunosuppression. Wiley, 2023.